Teva Pharmaceutical Industries Limited
TEVJF
$28.36
-$4.48-13.64%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 5.16% | 7.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 5.16% | 7.28% | |||
| Cost of Revenue | -5.51% | 4.92% | |||
| Gross Profit | 15.23% | 9.61% | |||
| SG&A Expenses | 15.11% | 1.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -288.89% | 80.00% | |||
| Total Operating Expenses | 0.35% | 4.02% | |||
| Operating Income | 20.54% | 19.24% | |||
| Income Before Tax | -86.11% | 217.65% | |||
| Income Tax Expenses | -282.24% | 374.36% | |||
| Earnings from Continuing Operations | 10.60% | 53.90% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 100.00% | -- | |||
| Net Income | 10.85% | 53.55% | |||
| EBIT | 20.54% | 19.24% | |||
| EBITDA | 17.49% | 14.85% | |||
| EPS Basic | 10.68% | 53.52% | |||
| Normalized Basic EPS | 29.22% | 29.14% | |||
| EPS Diluted | 10.43% | 54.17% | |||
| Normalized Diluted EPS | 28.46% | 28.84% | |||
| Average Basic Shares Outstanding | 0.17% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.77% | 0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||